Johnson & Johnson (JNJ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Johnson & Johnson | JNJ | Healthcare | Drug Manufacturers (Major) | 93 | 7.4% |
| Current Price (01/18) | $130.69 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 81,304.1 | |||
| Sales Growth Forecast | 5.8% | |||
| Net Profit Margin | 27.5% | |||
| Projected Shares Outstanding | 2,700.00 | |||
| EPS - Five year Forecast | $10.98 | |||
| Average P/E Ratio | 15.0 | |||
| Projected Average Price | $164.76 | |||
| Price Appreciation (Annualized) | 4.7% | |||
| Annual Dividend Yield | 2.7% | |||
| Projected Annual Return | 7.4% | |||
| Quality | ||||
| Financial Strength | 99 | 24.8 | ||
| EPS Stability | 98 | 24.6 | ||
| Industry Sales Growth Rate | 8.0% | 9.1 | ||
| Industry Net Profit Margin | 22.5% | 15.3 | ||
| Calculated Quality Rating | 73.7 | |||
| Fool CAPS | ||||
Total Players
13627
Outperforms
511
Underperforms
All-Stars (3153)
3089
Outperforms (98%)
64
Underperforms
|
||||
| Fundamental Data Updated: 11/16/2018 | ||||